Aug 2026
NAT10 promotes prostate cancer progression by acetylating mRNA of MARK2 and activating mTOR/HIF-1α/C-Myc pathway to enhance glycolytic reprogramming.
Yiming Zhang, Jian Wang, Ganping Wang et al.
· Cancer Gene Therapy · 0 citations